Accent’s Approach & Pipeline

Accent is taking a novel view of cancer – leveraging our industry-leading expertise in RNA-modifying protein (RMPs) biology. We look beyond mutation-specific vulnerabilities to identify and exploit critical intracellular dependencies that span multiple types of cancer and develop small molecule therapeutics designed to inhibit those targets and offer far-reaching potential for patients. Our approach has identified numerous high-value programs, both first-in-class and best-in-class, for which we strive to benefit large patient populations with significant unmet medical need.

5 parallel orange lines winding through circle containing up-close view of a cancer cell. Two small purple circles surround the main photo.
5 parallel orange lines winding through circle containing up-close view of a cancer cell. Two small purple circles surround the main photo.
Gray background with parallel blue lines weaving through circle containing a photo of an ACCENTuator in the lab. Two small orange circles surround the main photo.

Team

Our people are Accent. We are a highly experienced and collaborative team of ACCENTuators, all keenly focused on driving the translation of extraordinary science to life-changing therapies for patients.

Gray background with parallel blue lines weaving through circle containing a photo of an ACCENTuator in the lab. Two small orange circles surround the main photo.
1.23.24

Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies

10.10.23

Accent Therapeutics Unveils XRN1 Program and Provides Pipeline Update with Presentations at 35th AACR-NCI-EORTC Symposium

Wave shape
Wave shape